Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2

被引:21
|
作者
Mveang Nzoghe, Amandine [1 ]
Essone, Paulin N. [2 ,3 ,4 ]
Leboueny, Marielle [1 ]
Maloupazoa Siawaya, Anicet Christel [1 ]
Bongho, Eliode Cyrien [1 ]
Mvoundza Ndjindji, Ofilia [1 ]
Avome Houechenou, Rotimi Myrabelle [1 ]
Agnandji, Selidji Todagbe [2 ,3 ,4 ]
Djoba Siawaya, Joel Fleury [1 ]
机构
[1] Fdn Jeanne EBORI, CHU Mere Enfant, Serv Lab, Unite Rech & Diagnost Specialise, BP212, Libreville, Gabon
[2] Ctr Recherches Med Lambarene, Lambarene, Gabon
[3] Univ Tubingen, Inst Trop Med, Tubingen, Germany
[4] Univ Tubingen, German Ctr Infect Res, Tubingen, Germany
关键词
D O I
10.1002/iid3.367
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged throughout the world. Building knowledge around Covid-19 is crucial to devise facts based approaches to respond efficiently against this pandemic. Aim: We aimed to investigate pre-existing humoral cross-reactive immunity to SARS-CoV-2. Method: We have tested the reactivity against SARS-CoV-2 nucleocapsid (N) antigen of sera collected from healthy healthcare volunteers in 2014. We assessed immunoglobulins reactive against SARS-CoV-2 N-antigen using a well-validated serological platform; Elecsys assay. Results: Sera from 32 subjects (out of 135 [23.7%]) were reactive to SARS-CoV-2 N-antigen, suggesting the presence of anti-SARS-CoV-2 N-antigen antibodies. Conclusion: Although the clinical relevance of the observed reactivity can only be speculated and needs to be investigated, the implication of this finding for coronavirus disease 2019 seroepidemiological survey and vaccines' clinical trials is critical.
引用
收藏
页码:128 / 133
页数:6
相关论文
共 50 条
  • [31] Pre-existing immunity to SARS-CoV-2: the knowns and unknowns (vol 52, pg 891, 2020)
    Sette, Alessandro
    Crotty, Shane
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (10) : 644 - 644
  • [32] Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity
    Irene A. Abela
    Chloé Pasin
    Magdalena Schwarzmüller
    Selina Epp
    Michèle E. Sickmann
    Merle M. Schanz
    Peter Rusert
    Jacqueline Weber
    Stefan Schmutz
    Annette Audigé
    Liridona Maliqi
    Annika Hunziker
    Maria C. Hesselman
    Cyrille R. Niklaus
    Jochen Gottschalk
    Eméry Schindler
    Alexander Wepf
    Urs Karrer
    Aline Wolfensberger
    Silvana K. Rampini
    Patrick M. Meyer Sauteur
    Christoph Berger
    Michael Huber
    Jürg Böni
    Dominique L. Braun
    Maddalena Marconato
    Markus G. Manz
    Beat M. Frey
    Huldrych F. Günthard
    Roger D. Kouyos
    Alexandra Trkola
    Nature Communications, 12
  • [33] Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses
    Wratil, Paul R.
    Schmacke, Niklas A.
    Karakoc, Burak
    Dulovic, Alex
    Junker, Daniel
    Becker, Matthias
    Rothbauer, Ulrich
    Osterman, Andreas
    Spaeth, Patricia M.
    Ruhle, Adrian
    Gapp, Madeleine
    Schneider, Stephanie
    Muenchhoff, Maximilian
    Hellmuth, Johannes C.
    Scherer, Clemens
    Mayerle, Julia
    Reincke, Martin
    Behr, Juergen
    Kaab, Stefan
    Zwissler, Bernhard
    Von Bergwelt-Baildon, Michael
    Eberle, Josef
    Kaderali, Lars
    Schneiderhan-Marra, Nicole
    Hornung, Veit
    Keppler, Oliver T.
    CELL REPORTS, 2021, 37 (13):
  • [34] Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
    Henze, Larissa
    Braun, Julian
    Meyer-Arndt, Lil
    Juerchott, Karsten
    Schlotz, Maike
    Michel, Janine
    Grossegesse, Marica
    Mangold, Maike
    Dingeldey, Manuela
    Kruse, Beate
    Holenya, Pavlo
    Mages, Norbert
    Reimer, Ulf
    Eckey, Maren
    Schnatbaum, Karsten
    Wenschuh, Holger
    Timmermann, Bernd
    Klein, Florian
    Nitsche, Andreas
    Giesecke-Thiel, Claudia
    Loyal, Lucie
    Thiel, Andreas
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
    Lv, Huibin
    Wu, Nicholas C.
    Tsang, Owen Tak-Yin
    Yuan, Meng
    Perera, Ranawaka A. P. M.
    Leung, Wai Shing
    So, Ray T. Y.
    Chan, Jacky Man Chun
    Yip, Garrick K.
    Chik, Thomas Shiu Hong
    Wang, Yiquan
    Choi, Chris Yau Chung
    Lin, Yihan
    Ng, Wilson W.
    Zhao, Jincun
    Poon, Leo L. M.
    Peiris, J. S. Malik
    Wilson, Ian A.
    Mok, Chris K. P.
    CELL REPORTS, 2020, 31 (09):
  • [36] Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
    Grobben, Marloes
    van der Straten, Karlijn
    Brouwer, Philip J. M.
    Brinkkemper, Mitch
    Maisonnasse, Pauline
    Dereuddre-Bosquet, Nathalie
    Appelman, Brent
    Lovell, A. H. Ayesha
    van Vught, Lonneke A.
    Burger, Judith A.
    Poniman, Meliawati
    Oomen, Melissa
    Eggink, Dirk
    Bijl, Tom P. L.
    van Willigen, Hugo D. G.
    Wynberg, Elke
    Verkaik, Bas J.
    Figaroa, Orlane J. A.
    de Vries, Peter J.
    Boertien, Tessel M.
    Bomers, Marije K.
    Sikkens, Jonne J.
    Le Grand, Roger
    de Jong, Menno D.
    Prins, Maria
    Chung, Amy W.
    de Bree, Godelieve J.
    Sanders, Rogier W.
    van Gils, Marit J.
    ELIFE, 2021, 10
  • [37] Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020
    de Oliveira-Filho, Edmilson F.
    de Carvalho, Otavio V.
    Carneiro, Ianei O.
    Fernandes, Fagner D'ambroso
    Vaz, Sara Nunes
    Pedroso, Celia
    Gonzalez-Auza, Lilian
    Urbieta, Victor Carvalho
    Kuehne, Arne
    Mayoral, Rafaela
    Jo, Wendy K.
    Moreira-Soto, Andres
    Reusken, Chantal B. E. M.
    Drosten, Christian
    Brites, Carlos
    Osterrieder, Klaus
    Netto, Eduardo Martins
    Ristow, Luiz Eduardo
    Maia, Rita de Cassia
    Vogel, Fernanda S. Flores
    de Almeida, Nadia Rossi
    Franke, Carlos Roberto
    Drexler, Jan Felix
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [38] Pre-existing diabetes is worse for SARS-CoV-2 infection; an endothelial perspective
    La Sala, Lucia
    Luzi, Livio
    Pontiroli, Antonio E.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2020, 30 (10) : 1855 - 1856
  • [39] Reduced Frequency of SARS-CoV-2 Symptom and RNAemia Development in Pre-Symptomatic Blood Donors with Pre-Existing Immunity
    Saa, P.
    Fink, R.
    Di Germanio, C.
    Krysztof, D.
    Nester, T.
    Kessler, D.
    Townsend, R.
    Kamel, H.
    Stone, M.
    Norris, P.
    TRANSFUSION, 2023, 63 : 63A - 64A
  • [40] Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
    Milighetti, Martina
    Peng, Yanchu
    Tan, Cedric
    Mark, Michal
    Nageswaran, Gayathri
    Byrne, Suzanne
    Ronel, Tahel
    Peacock, Tom
    Mayer, Andreas
    Chandran, Aneesh
    Rosenheim, Joshua
    Whelan, Matthew
    Yao, Xuan
    Liu, Guihai
    Felce, Suet Ling
    Dong, Tao
    Mentzer, Alexander J.
    Knight, Julian C.
    Balloux, Francois
    Greenstein, Erez
    Reich-Zeliger, Shlomit
    Pade, Corinna
    Gibbons, Joseph M.
    Semper, Amanda
    Brooks, Tim
    Otter, Ashley
    Altmann, Daniel M.
    Boyton, Rosemary J.
    Maini, Mala K.
    McKnight, Aine
    Manisty, Charlotte
    Treibel, Thomas A.
    Moon, James C.
    COVIDsortium Investigators, COVIDsortium Investigators
    Noursadeghi, Mahdad
    Chain, Benny
    ISCIENCE, 2023, 26 (06)